Zheng Haixue, Lian Kaiqi, Yang Fan, Jin Ye, Zhu Zixiang, Guo Jianhong, Cao Weijun, Liu Huanan, He Jijun, Zhang Keshan, Li Dan, Liu Xiangtao
State Key Laboratory of Veterinary Etiological Biology, National Foot and Mouth Diseases Reference Laboratory, Key Laboratory of Animal Virology of Ministry of Agriculture, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou, China.
State Key Laboratory of Veterinary Etiological Biology, National Foot and Mouth Diseases Reference Laboratory, Key Laboratory of Animal Virology of Ministry of Agriculture, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou, China.
Vaccine. 2015 Oct 26;33(43):5772-5778. doi: 10.1016/j.vaccine.2015.09.055. Epub 2015 Oct 1.
Foot-and-mouth disease (FMD) is a highly contagious vesicular disease that affects domestic and wild cloven-hoofed animals worldwide. Recently, a series of outbreaks of type A FMDV occurred in Southeast Asian countries, China, the Russia Federation, Mongolia, Kazakhstan and South Korea. The FMD virus (A/GDMM/CHA/2013) from China's Guangdong province (2013) is representative of those responsible for the latest epidemic, and has low amino acid identity (93.9%) in VP1 protein with the epidemic strain A/WH/CHA/09 from Wuhan, China in 2009. Both of isolates belong to the Sea-97 genotype of ASIA topotype. Therefore, the application of a new vaccine strain with cross-protective efficacy is of fundamental importance to control the spread of the two described pandemic strains. A chimeric strain rA/P1-FMDV constructed by our lab previously through replacing the P1 gene in the vaccine strain O/CHA/99 with that from the epidemic stain A/WH/CHA/09, has been demonstrated to exhibit good growth characteristics in culture, and the rA/P1-FMDV inactivated vaccine can provide protection against epidemic strain A/WH/CHA/09 in cattle. However, it is still unclear whether the vaccine produces efficient protection against the new pandemic strain (A/GDMM/CHA/2013). Here, vaccine matching and pig 50% protective dose (PD50) tests were performed to assess the vaccine potency. The vaccine matching test showed cross-reactivity of sera from full dose vaccine vaccinated pigs with A/WH/CHA/09 and A/GDMM/CHA/2013 isolates, with average r1 values of 0.94±0.12 and 0.68±0.06 (r1≥0.3), which indicates that the rA/P1-FMDV vaccine is likely to confer good cross-protection against the two isolates. When challenged with two pandemic isolates A/WH/CHA/09 and A/GDMM/CHA/2013 strain, the vaccine achieved 12.51 PD50 and 10.05 PD50 per dose (2.8μg), respectively. The results indicated that the rA/P1-FMDV inactivated vaccine could protect pigs against both A/WH/CHA/09 and A/GDMM/CHA/2013 pandemic isolates.
口蹄疫(FMD)是一种高度传染性的水疱性疾病,影响着全球范围内的家养和野生偶蹄类动物。最近,一系列A型口蹄疫病毒(FMDV)疫情在东南亚国家、中国、俄罗斯联邦、蒙古、哈萨克斯坦和韩国爆发。来自中国广东省(2013年)的口蹄疫病毒(A/GDMM/CHA/2013)是引发此次最新疫情的代表性毒株,其VP1蛋白与2009年来自中国武汉的流行毒株A/WH/CHA/09的氨基酸同源性较低(93.9%)。这两种毒株均属于亚洲拓扑型的Sea-97基因型。因此,应用具有交叉保护效力的新型疫苗株对于控制上述两种大流行毒株的传播至关重要。我们实验室先前通过用来自流行毒株A/WH/CHA/09的P1基因替换疫苗株O/CHA/99中的P1基因构建的嵌合毒株rA/P1-FMDV,已被证明在培养中具有良好的生长特性,并且rA/P1-FMDV灭活疫苗能够为牛群提供针对流行毒株A/WH/CHA/09的保护。然而,该疫苗是否能对新的大流行毒株(A/GDMM/CHA/2013)产生有效的保护作用仍不清楚。在此,进行了疫苗匹配和猪50%保护剂量(PD50)试验以评估疫苗效力。疫苗匹配试验显示,全剂量疫苗接种猪的血清与A/WH/CHA/09和A/GDMM/CHA/2013毒株具有交叉反应性,平均r1值分别为0.94±0.12和0.68±0.06(r1≥0.3),这表明rA/P1-FMDV疫苗可能对这两种毒株提供良好的交叉保护。当用两种大流行毒株A/WH/CHA/09和A/GDMM/CHA/2013进行攻毒时,该疫苗每剂量(2.8μg)分别达到了12.51 PD50和10.05 PD50。结果表明,rA/P1-FMDV灭活疫苗能够保护猪抵抗A/WH/CHA/09和A/GDMM/CHA/2013这两种大流行毒株。